Search Details

Word: cancerous (lookup in dictionary) (lookup stats)
Dates: all
Sort By: most recent first (reverse)


Usage:

...those tasks, he brought his superabundant energies, look-at-me narcissism and gleefully roguish manner. But in one job, he left the world a changed place. In his 10 years as director of New York's Metropolitan Museum of Art, Hoving, who was 78 when he died of cancer on Dec. 10, didn't just transform the Met. He remade the very idea of museums...

Author: /time Magazine | Title: Thomas Hoving: The Man Who Made the Modern Met | 12/11/2009 | See Source »

...he’s trying to cure cancer. The biochemistry concentrator, who is a student in the secondary field in Health Policy, experiments with using viruses as cancer therapies for his senior thesis...

Author: By Nora A. Tufano, CRIMSON STAFF WRITER | Title: 15 Most Interesting seniors 2010: Nworah B. Ayogu | 12/11/2009 | See Source »

Born in Taiwan, Ho was 12 years old when his father lost an eight-year battle against cancer, and his mother was institutionalized for illness shortly thereafter. Adopted by a sympathetic aunt, Ho arrived in the United States at the age of 13, unable to speak English and never having played football. “He’s a great example of the human spirit,” says Coach Tim L. Murphy, Head Coach for Harvard Football. “What are the odds that a kid who lands in the United States basically as an orphan with...

Author: By Stephanie M. Woo, CRIMSON STAFF WRITER | Title: 15 Most Interesting Seniors 2010: Kai-Cheng Ho | 12/11/2009 | See Source »

Based on this and other studies, the U.S. Preventive Services Task Force said there was insufficient evidence to assess the balance of benefits and harms of prostate-cancer screening in men younger than age 75. The task force recommended against prostate-cancer screening in men 75 and older...

Author: /time Magazine | Title: TIME's Top 10 Medical Breakthroughs of 2009 | 12/8/2009 | See Source »

...different way ? by curbing the formation of the bone-gnawing cells. That tilts the balance in favor of bone-building. In two studies published in August, the experimental compound denosumab was shown to reduce the risk of fractures in postmenopausal women as well as men being treated for prostate cancer, the two largest patient populations at risk for bone loss. What's not clear, however, is how the new drug, if approved, would compare with existing osteoporosis drugs like Fosamax, Boniva and Reclast...

Author: /time Magazine | Title: TIME's Top 10 Medical Breakthroughs of 2009 | 12/8/2009 | See Source »

Previous | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | Next